Genes2Me
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Genes2Me is a biotechnology, genetics, and health care company that develops and manufactures in-vitro diagnostic (IVD) solutions, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, and RT-PCR kits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genes2Me Comparables
Compare Genes2Me with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mylab Discovery Solutions | 86% | |
| NeoDx Biotech Labs | 81% | |
| GenePath Diagnostics | 80% |
Genes2Me Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 27, representing 24% of headcount.
- May 17, 2026
Monthly visitors increased 44% MoM, from 3.9K to 5.7K.
Recent news
Latest coverage and updates
- launchesJul 25, 2026
Genes2Me Private Limited launches CliSeq Interpreter.
- launchesJul 16, 2026
Genes2Me Private Limited launches RT-PCR portfolio.
- launchesJul 2, 2026
Genes2Me Pvt. Ltd. launches targeted TB NGS assay.
Genes2Me Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genes2Me's valuation, stock price, and market status.
Is Genes2Me a public or private company?
Genes2Me is a private company.
What is the current stock price of Genes2Me?
Genes2Me is a private company with no public stock price. No recent secondary market data is available.
How much is Genes2Me worth (valuation)?
Valuation information for Genes2Me is not publicly available.
Can I buy Genes2Me stock?
Genes2Me shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genes2Me's last funding round?
Funding round information for Genes2Me is not publicly available.
Who are the main investors in Genes2Me?
Investor information for Genes2Me is not publicly disclosed.
Will Genes2Me IPO soon?
No public IPO plans have been announced for Genes2Me.
How can I track Genes2Me secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genes2Me's secondary market activity and sign up for updates.